Dispersome® – Understanding formulation principles and manufacturing behind this new Bioavailability Enhancing Technology
September 08, 2022
Thursday, September 8, 2022 at 11am EDT; 4pm GMT; 5pm CEST
This webinar will highlight the new solubility enhancing Dispersome® technology, which is based on the amorphous stabilization of a given drug using the protein beta-lactoglobulin (BLG) as novel pharmaceutical excipient. Several relevant case studies are presented to showcase the potential of this new technology. Subsequently, the webinar provides a roadmap on how these formulations can be manufactured on a commercial scale. The webinar will also cover the manufacturing of the formulations.